• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 3.5/22; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 3.5/22; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 364503
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Death (1802); Thrombosis (2100)
Event Date 05/27/2020
Event Type  Death  
Event Description
An orsiro drug-eluting stent system was selected for treatment.20 day after primary intervention patient experienced chest pain.Stent thrombosis was detected.Pcta was done, blood flow was resolved but patient remained in icu.The day after patient passed away.The physician stated that the thrombosis occurred due to discontinuing antiplatelet medicine.
 
Manufacturer Narrative
Neither the complaint instrument nor the angiographic material was available for analysis.Therefore no technical investigation on the subject could be performed.The production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.Review of the production documentation confirmed that the instrument was manufactured according to specifications and passed all in-process and final inspections.Based on the conducted investigations no manufacturing related root cause was determined.There are a number of factors contributing to stent thrombosis.In the present case appropriate preventative measures were taken, but antiplatelet/anticoagulation medication was discontinued independently two days after stent implantation.The root cause for the complaint event is therefore most likely related to external factors, i.E.The discontinuation of prescribed antiplatelet/anticoagulation medication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO 3.5/22
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key10123422
MDR Text Key194141222
Report Number1028232-2020-02281
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 06/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/05/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/14/2021
Device Model Number364503
Device Catalogue NumberSEE MODEL NO.
Device Lot Number07193094
Was Device Available for Evaluation? No
Date Manufacturer Received07/27/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
-
-